COMMUNIQUÉS West-GlobeNewswire

Italfarmaco Announces Managed Entry Agreement in Georgia for Givinostat as Treatment for Patients with Duchenne Muscular Dystrophy
31/07/2026
MILAN, Italy, July 31, 2026 – Italfarmaco S.p.A. today announced a managed entry agreement with the Georgian Ministry of Health for givinostat (Duvyzat ® ) as a treatment for patients with Duchenne muscular dystrophy ( [...]
Ally Medical Emergency Room's Record-Breaking Pet Supply Donation Drive Returns Bigger Than Ever This August
31/07/2026
Following last year's record 6,000+ items collected, Texans across Austin, Dallas-Fort Worth and Houston areas can donate pet supplies at any Ally Medical ER location Aug. 1-31 to benefit Austin Pets Alive!, Dallas Pets [...]
Rose Hill Life Sciences and Control Z Sign Letter of Intent to Advance Clinically Structured Psilocybin-Assisted Therapy for PTSD
31/07/2026
Partnership establishes the framework for the first regulated psychedelic therapy program in the Commonwealth, uniting Rose Hill’s pharmaceutical-grade Psychedelic Therapeutic Intervention (PTI)™ protocol with Control Z [...]
Former First Baptist Medical Center Acquired By St Raphael Health - Dallas
31/07/2026
New ownership brings a renewed team, a more welcoming hospital experience, and stronger connections for Dallas patients, surgeons, physicians, families, and community partners DALLAS, July 31, 2026 (GLOBE NEWSWIRE) -- [...]
NewcelX Announces Pricing of $1.4 Million Equity Financing at 20% Premium Pricing
31/07/2026
Private Financing Reflects Strong Investor Confidence and Supports Advancement of Lead Type 1 Diabetes Program Following Successful FDA Pre-IND Meeting ZURICH, Switzerland, July 31, 2026 (GLOBE NEWSWIRE) -- NewcelX Ltd [...]
Scientific Paper Detailing Preclinical Studies of Narmafotinib in Pancreatic Cancer Now Online
31/07/2026
HIGHLIGHTS A manuscript describing comprehensive preclinical studies of narmafotinib in models of pancreatic cancer is now available online. The findings provide further evidence of narmafotinib's ability to target [...]
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
31/07/2026
SEATTLE and VANCOUVER, British Columbia, July 31, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and [...]
NOMAD Power Solutions Announces Options Trading Begins on Cboe Options Exchange
31/07/2026
Boca Raton, Fla., July 31, 2026 (GLOBE NEWSWIRE) -- NOMAD Power Solutions, Inc. ("NOMAD" or the "Company") (Nasdaq: NMAD), a leader in transportable, utility-grade battery energy storage systems through its wholly owned [...]
Stablecoin Development Corporation Reports Second Quarter 2026 Financial Results
31/07/2026
Staking revenue of $2.2 million for the quarter and $4.7 million for the first half of 2026 SDEV grew its SKY position to 2.29 billion tokens (approximately 10% of total SKY supply) and eliminated all remaining warrant [...]
Cerenome Launches as an Integrated CNS Oncology Company
31/07/2026
Formerly known as Plus Therapeutics, Cerenome integrates precision diagnostics, targeted therapeutics, and artificial intelligence to improve how CNS cancers are detected, treated, and understood HOUSTON, July 31, 2026 [...]
BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance
31/07/2026
LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex [...]
Telix H1 2026 Results: Investor Webcast Notification
31/07/2026
MELBOURNE, Australia and INDIANAPOLIS, July 31, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today advises that it will release its financial results for the half-year ended [...]
Laguna Treatment Center Now Offers Virtual Outpatient Services for those Struggling with Addiction
31/07/2026
ALISO VIEJO, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- Laguna Treatment Center, a leading provider of addiction treatment in Southern California, has expanded its services with the addition of a virtual intensive [...]
ColestZen Launch 2026 - Healthy Cholesterol Support Formula With 18 Ingredients In (US, UK, CA, AU).ColestZen Capsule Benefits and Supplement Facts
31/07/2026
ColestZen Capsule introduces 2026 marks the introduction of a effective and healthy cholesterol support capsule formulated with a blend of 18 botanical ingredients and essential micronutrients. Designed to complement [...]
Replimune Announces Favorable Outcome of FDA's Cellular, Tissue, and Gene Therapies Advisory Committee Meeting for RP1 in Advanced Melanoma
31/07/2026
Advisory Committee voted 10 to 3 that the efficacy results from the IGNYTE study are evaluable and clinically meaningful WOBURN, Mass., July 30, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical- [...]
Sanuwave Will Host a Conference Call on August 7, 2026 at 8:30 AM (ET) to Present Q2 2026 Financial Results
31/07/2026
EDEN PRAIRIE, Minn., July 30, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live [...]
SodaSlim Official Launch 2026 Natural Weight Loss Capsules For metabolic and appetite support in USA. Soda Slim Highlights Ingredient and Supplement Facts
30/07/2026
Company Introduced SodaSlim Capsules a natural dietary supplement created to support healthy metabolism and weight management as part of a balanced lifestyle. Formulated with carefully selected ingredients and essential [...]
DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on Nasdaq
30/07/2026
Châtillon, France, July 30, 2026 DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on Nasdaq DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq [...]
DBV Technologies annonce le placement d’ADS pour un montant d’environ 50 millions de Dollars US dans le cadre de son programme At-The-Market (ATM) sur le Nasdaq
30/07/2026
Châtillon, France, 30 juillet 2026 DBV Technologies annonce le placement d’ADS pour un montant d’environ 50 millions de Dollars US dans le cadre de son programme At-The-Market (ATM) sur le Nasdaq DBV Technologies (la « [...]

Pages